Coral Laboratories Limited (BOM:524506)
574.00
-11.00 (-1.88%)
At close: Sep 4, 2026
Coral Laboratories Market Cap
Coral Laboratories has a market cap or net worth of 2.05 billion as of September 4, 2026. Its market cap has increased by 16.14% in one year.
Market Cap
2.05B
Enterprise Value
1.08B
Revenue
967.01M
Ranking
n/a
PE Ratio
10.68
Stock Price
574.00
ChartMarket Cap Chart
Since August 4, 1998, Coral Laboratories's market cap has increased from 39.30M to 2.05B, an increase of 5,118.18%. That is a compound annual growth rate of 15.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 2.05B | 30.90% |
| Dec 31, 2025 | 1.57B | -42.52% |
| Dec 31, 2024 | 2.73B | 75.31% |
| Dec 29, 2023 | 1.55B | 35.01% |
| Dec 30, 2022 | 1.15B | 3.55% |
| Dec 31, 2021 | 1.11B | 0.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gennex Laboratories | 2.87B |
| Astonea Labs | 2.84B |
| Everest Organics | 2.64B |
| Sanjivani Paranteral | 2.34B |
| Accretion Pharmaceuticals | 2.25B |
| Bilcare | 2.24B |
| Kerala Ayurveda | 2.19B |
| Oxygenta Pharmaceutical | 2.07B |